Matica Enterprises Inc. (CSE:MMJ;FWB:39N;OTCPink:MQPXF) (“Matica” or the “Company”) is pleased to announce that it has retained Maricom Inc. (“Maricom”) to provide investor relations services to the Company in compliance with regulatory guidelines.

Matica Engages Maricom


Maricom is a Quebec-based communications firm focused on providing fully bilingual investor relations services to build and create awareness for companies in all stages of development in every key network. The firm brings unique expertise in the cannabis sector and will be providing a range of services, including presenting Matica’s business and milestones to a network of investment advisors, analysts and institutional fund managers.

Maricom will work closely with Matica to develop and deploy a comprehensive capital markets strategy and campaign. Activities will include developing precise messaging, distributing that message cost-effectively and optimizing the Company’s branding, website and social media presence bilingually with Maricom’s graphic design and social media team.

Under the terms of engagement, Maricom has been retained for a six and a half period starting December 15th 2018 at $3,000 per month. The Company has also granted 500,000 stock options exercisable at $0.10 to Maricom.

About Maricom

Maricom is a Quebec-based firm who provide a fully bilingual investor relations service. Their focus is mainly in Quebec via a strong French network as well as extensive ties and direct relationships with Bay Street to ensure their clients have strong exposure throughout Canada and beyond.

About Matica

Matica is a multi-faceted, innovative company in the Quebec cannabis space. Matica has a 70% interest in RoyalMax Biotechnology Canada Inc. (“RoyalMax”). RoyalMax was recently granted a cultivation licence by Health Canada for the fully completed 10,000 square foot production facility in Dorval, Quebec. RoyalMax is one of only 11 Licensed Producers in the Province of Quebec. Matica is also building 1,000,000 square feet of greenhouses on a 181 acre property in the township of Hemmingford, south of Montreal. Matica has entered into an agreement to acquire a 40% position in Yunify Natural Technologies, a Quebec based health and personal care research and innovation company.

For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.

On behalf of the Board of Directors

MATICA ENTERPRISES INC.

Boris Ziger

Boris Ziger, CEO & Chairman

The Company’s public filings are available for review at www.sedar.com and www.thecse.com.

For further information, please contact Remy Scalabrini, Investor Relations, at:

Telephone: 1(888) 585-6274

E-mail: info@maticaenterprises.com

Website: www.maticaenterprises.com

Disclaimer for Forward-Looking Information

Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at www.sedar.com.

This news release contains statements about the Company’s information that may be made available on the S&P Capital IQ Corporation Records Listing Program and the business of Matica that are forward-looking in nature and as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.

Click here to connect with Matica Enterprises Inc. (CSE:MMJ;FWB:39N;OTCPink:MQPXF) for an Investor Presentation. 

Source: www.thenewswire.com

Two US-based multi-state operators (MSOs) added fuel to the ongoing merger and acquisition (M&A) train currently making its way across the cannabis sector.

On the flip side, one of Canada’s biggest cannabis producers told the market this week that it has no interest in further acquisitions in the Canadian market.

Keep reading... Show less

 Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”), a wellness company that makes and sells plant-based products, is ramping up production at its Victoria, BC production facility to fulfill incoming orders from seven Whole Foods Market in Ontario, Canada (“Whole Foods”).

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/84022_947985ee845d7afb_001.jpg

Keep reading... Show less
  • Domestic Medical Net Revenue Steady at $26.9 Million
  • Strong International Medical Net Revenue of $9.4 Million
  • Total Cannabis Net Revenue, Excluding Provisions, of $58.4 Million
  • Business Transformation Plan Continues, Management Expects to Deliver Incremental Cost-Saving Measures of $60 Million to $80 Million Annually
  • Balance Sheet Remains Strong with ~$525 Million of Cash on Hand at May 12, 2021
  • Lead Independent Director Ronald Funk Appointed as Chairman, Michael Singer to Remain Board Member

NYSE | TSX: ACB

 Aurora Cannabis Inc. (the ” Company ” or ” Aurora “) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the third quarter of fiscal 2021 ended March 31, 2021 .

Keep reading... Show less

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies

Keep reading... Show less

Experienced executives fill senior roles in business development, M&A, clinic operations and design, and corporate communications

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced the appointments of five experienced leaders to support strategic growth initiatives across the Company’s three divisions Numinus Health, Numinus R&D and Numinus Bioscience.

Keep reading... Show less